Free Widgets | Feedback 
Live Share Markets -

Updated:18 Oct 2017 03:31:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 914.50 [ +4.59% ]TCS 2586.60 [ -0.31% ]

-24.81 -0.08%

-23.60 -0.23%

1.48 0.01%

-2.76 -0.02%

Bse Corporate Announcements Back
Lupin launches Zaxine® in Canada
Lupin announced that its Canadian subsidiary, Lupin Pharma Canada has launched its first brand product Zaxine® under strategic licensing agreement with the North Carolina based GI specialty company, Salix Pharmaceuticals Inc. The agreement grants Lupin exclusive rights to promote, distribute and market Zaxine® in the Canada.

Zaxine® 550mg (rifaximin) is a long term antibiotic treatment for adults living with hepatic encephalopathy (HE), a complication of liver disease (cirrhosis).

Market on Mobile

Site Map  •  Mobile  •  Companies  •  Learning Centre  •  Insurance •  About  •  Contact us  •  Disclaimer